Clinical Trial Update: Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant [Phase 1]

View source ↗

Summary

The study evaluated transfusing KIR-ligand mismatched haplo-identical natural killer (NK) cells before autologous stem cell transplantation in patients with mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• KIR-ligand mismatched haplo-identical natural killer cells (Natural killer cells)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED